Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 294
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02525029 | Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD | ||
| NCT00176930 | Stem Cell Transplant for Hematological Malignancy | ||
| NCT01451502 | Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units | ||
| NCT04928950 | Charcoal in Lung Cancer Patients Undergoing TEMLA | ||
| NCT03579875 | Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders | ||
| NCT00258427 | Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia | ||
| NCT01566682 | A Multi-Center Trial of the ProLung Test™ | ||
| NCT00274846 | Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia | ||
| NCT00895414 | Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer | ||
| NCT02227797 | MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients | ||
| NCT05338658 | Study of PAT in Patients With Solid Tumor Cancers | ||
| NCT04466098 | Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) | ||
| NCT00478244 | Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa | ||
| NCT00855114 | Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery | ||
| NCT00618696 | Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia | ||
| NCT00381888 | Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer | ||
| NCT02162420 | Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia | ||
| NCT04630769 | FT516 and IL2 With Enoblituzumab for Ovarian Cancer | ||
| NCT00630253 | Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia | ||
| NCT00963872 | Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer | ||
| NCT00000105 | Vaccination With Tetanus and KLH to Assess Immune Responses. | ||
| NCT04882423 | Vegetable Intake Effect on Heterocyclic Amine Metabolism | ||
| NCT05708703 | Assessing the Time Demands of Cancer | ||
| NCT01526603 | High Dose Chemotherapy and Autologous Transplant for Neuroblastoma | ||
| NCT01705288 | Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study | ||
| NCT02845414 | Study of CD133KDEL Toxin in the Treatment for Solid Tumors | ||
| NCT00167206 | Stem Cell Transplantation for Fanconi Anemia | ||
| NCT04055844 | Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS | ||
| NCT06584929 | Rural Smoking Cessation | ||
| NCT03297463 | Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma | ||
| NCT04858594 | Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy | ||
| NCT01639456 | CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission | ||
| NCT00167180 | Post Transplant Donor Lymphocyte Infusion | ||
| NCT03978117 | Clinical Trial of Two Study Drinks in Detoxification of Environmental Toxicants and Carcinogens | ||
| NCT00176826 | T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders | ||
| NCT00369291 | CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant | ||
| NCT00290641 | Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer | ||
| NCT00167219 | Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML) | ||
| NCT02171104 | MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis | ||
| NCT04228952 | Metabolism of NNK in Japanese Americans | ||
| NCT01012362 | Study of Pazopanib and Ixabepilone in Patients With Solid Tumors | ||
| NCT00303667 | Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant | ||
| NCT02141451 | ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL | ||
| NCT01560923 | Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer | ||
| NCT01099631 | IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread | ||
| NCT03125642 | Auto Stem Cell Transplant for Lymphoma Patients | ||
| NCT01163201 | T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies | ||
| NCT01343368 | Preservation of Ovarian Function After Hematopoietic Cell Transplant | ||
| NCT02309944 | Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients | ||
| NCT01677949 | Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia |
